Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge

Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge

Submitted by admin on March 13, 2018 - 10:15am
Source: 
Endpoints
News Tags: 
FDA
Advair
AstraZeneca
Imfinzi
clinical trials
Headline: 
Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge

Do Not Allow Advertisers to Use My Personal information